- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-3-mer
- Ligands
- 3 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 21 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG-NAG.2: 3 residues within 4Å:- Chain A: S.355, G.356, N.359
No protein-ligand interaction detected (PLIP)NAG-NAG.6: 7 residues within 4Å:- Chain A: Q.261, N.263, N.299, V.300, S.379, R.410
- Ligands: NAG-NAG.11
No protein-ligand interaction detected (PLIP)NAG-NAG.7: 4 residues within 4Å:- Chain A: Q.98, S.118, N.120, K.131
No protein-ligand interaction detected (PLIP)NAG-NAG.9: 5 residues within 4Å:- Chain A: V.142, R.160, N.165, T.166
- Chain I: R.276
No protein-ligand interaction detected (PLIP)NAG-NAG.10: 3 residues within 4Å:- Chain A: E.55, N.56
- Chain B: S.9
No protein-ligand interaction detected (PLIP)NAG-NAG.11: 6 residues within 4Å:- Chain A: T.265, N.299, S.379, T.381, R.410
- Ligands: NAG-NAG.6
No protein-ligand interaction detected (PLIP)NAG-NAG.12: 3 residues within 4Å:- Chain A: N.269, I.290, V.408
No protein-ligand interaction detected (PLIP)NAG-NAG.14: 3 residues within 4Å:- Chain E: S.355, G.356, N.359
No protein-ligand interaction detected (PLIP)NAG-NAG.18: 7 residues within 4Å:- Chain E: Q.261, N.263, N.299, V.300, S.379, R.410
- Ligands: NAG-NAG.23
No protein-ligand interaction detected (PLIP)NAG-NAG.19: 4 residues within 4Å:- Chain E: Q.98, S.118, N.120, K.131
No protein-ligand interaction detected (PLIP)NAG-NAG.21: 5 residues within 4Å:- Chain A: R.276
- Chain E: V.142, R.160, N.165, T.166
No protein-ligand interaction detected (PLIP)NAG-NAG.22: 3 residues within 4Å:- Chain E: E.55, N.56
- Chain F: S.9
No protein-ligand interaction detected (PLIP)NAG-NAG.23: 6 residues within 4Å:- Chain E: T.265, N.299, S.379, T.381, R.410
- Ligands: NAG-NAG.18
No protein-ligand interaction detected (PLIP)NAG-NAG.24: 3 residues within 4Å:- Chain E: N.269, I.290, V.408
No protein-ligand interaction detected (PLIP)NAG-NAG.26: 3 residues within 4Å:- Chain I: S.355, G.356, N.359
No protein-ligand interaction detected (PLIP)NAG-NAG.30: 7 residues within 4Å:- Chain I: Q.261, N.263, N.299, V.300, S.379, R.410
- Ligands: NAG-NAG.35
No protein-ligand interaction detected (PLIP)NAG-NAG.31: 4 residues within 4Å:- Chain I: Q.98, S.118, N.120, K.131
No protein-ligand interaction detected (PLIP)NAG-NAG.33: 5 residues within 4Å:- Chain E: R.276
- Chain I: V.142, R.160, N.165, T.166
No protein-ligand interaction detected (PLIP)NAG-NAG.34: 3 residues within 4Å:- Chain I: E.55, N.56
- Chain J: S.9
No protein-ligand interaction detected (PLIP)NAG-NAG.35: 6 residues within 4Å:- Chain I: T.265, N.299, S.379, T.381, R.410
- Ligands: NAG-NAG.30
No protein-ligand interaction detected (PLIP)NAG-NAG.36: 3 residues within 4Å:- Chain I: N.269, I.290, V.408
No protein-ligand interaction detected (PLIP)- 12 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA.3: 5 residues within 4Å:- Chain A: N.353, S.355
- Ligands: NAG-NAG-BMA-MAN.1, NAG-NAG-BMA-MAN.1, NAG-NAG-BMA-MAN.1
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.4: 7 residues within 4Å:- Chain A: L.229, N.230, G.346, C.411, V.412, S.413
- Ligands: NAG.37
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:G.346
NAG-NAG-BMA.5: 7 residues within 4Å:- Chain A: N.244
- Chain D: Y.26, G.27, S.28, W.63, G.64, Y.87
1 PLIP interactions:1 interactions with chain D- Hydrogen bonds: D:G.27
NAG-NAG-BMA.8: 3 residues within 4Å:- Chain A: N.116, Y.133, D.288
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.15: 5 residues within 4Å:- Chain E: N.353, S.355
- Ligands: NAG-NAG-BMA-MAN.13, NAG-NAG-BMA-MAN.13, NAG-NAG-BMA-MAN.13
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.16: 7 residues within 4Å:- Chain E: L.229, N.230, G.346, C.411, V.412, S.413
- Ligands: NAG.42
1 PLIP interactions:1 interactions with chain E- Hydrogen bonds: E:G.346
NAG-NAG-BMA.17: 7 residues within 4Å:- Chain E: N.244
- Chain H: Y.26, G.27, S.28, W.63, G.64, Y.87
1 PLIP interactions:1 interactions with chain H- Hydrogen bonds: H:G.27
NAG-NAG-BMA.20: 3 residues within 4Å:- Chain E: N.116, Y.133, D.288
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.27: 5 residues within 4Å:- Chain I: N.353, S.355
- Ligands: NAG-NAG-BMA-MAN.25, NAG-NAG-BMA-MAN.25, NAG-NAG-BMA-MAN.25
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.28: 7 residues within 4Å:- Chain I: L.229, N.230, G.346, C.411, V.412, S.413
- Ligands: NAG.47
1 PLIP interactions:1 interactions with chain I- Hydrogen bonds: I:G.346
NAG-NAG-BMA.29: 7 residues within 4Å:- Chain I: N.244
- Chain L: Y.26, G.27, S.28, W.63, G.64, Y.87
1 PLIP interactions:1 interactions with chain L- Hydrogen bonds: L:G.27
NAG-NAG-BMA.32: 3 residues within 4Å:- Chain I: N.116, Y.133, D.288
No protein-ligand interaction detected (PLIP)- 15 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.37: 4 residues within 4Å:- Chain A: P.259, V.412, N.414
- Ligands: NAG-NAG-BMA.4
Ligand excluded by PLIPNAG.38: 1 residues within 4Å:- Chain A: N.322
Ligand excluded by PLIPNAG.39: 2 residues within 4Å:- Chain A: N.101, K.115
Ligand excluded by PLIPNAG.40: 3 residues within 4Å:- Chain A: N.306, E.307, W.362
Ligand excluded by PLIPNAG.41: 2 residues within 4Å:- Chain B: N.92, S.94
Ligand excluded by PLIPNAG.42: 4 residues within 4Å:- Chain E: P.259, V.412, N.414
- Ligands: NAG-NAG-BMA.16
Ligand excluded by PLIPNAG.43: 1 residues within 4Å:- Chain E: N.322
Ligand excluded by PLIPNAG.44: 2 residues within 4Å:- Chain E: N.101, K.115
Ligand excluded by PLIPNAG.45: 3 residues within 4Å:- Chain E: N.306, E.307, W.362
Ligand excluded by PLIPNAG.46: 2 residues within 4Å:- Chain F: N.92, S.94
Ligand excluded by PLIPNAG.47: 4 residues within 4Å:- Chain I: P.259, V.412, N.414
- Ligands: NAG-NAG-BMA.28
Ligand excluded by PLIPNAG.48: 1 residues within 4Å:- Chain I: N.322
Ligand excluded by PLIPNAG.49: 2 residues within 4Å:- Chain I: N.101, K.115
Ligand excluded by PLIPNAG.50: 3 residues within 4Å:- Chain I: N.306, E.307, W.362
Ligand excluded by PLIPNAG.51: 2 residues within 4Å:- Chain J: N.92, S.94
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Henderson, R. et al., Disruption of the HIV-1 Envelope allosteric network blocks CD4-induced rearrangements. Nat Commun (2020)
- Release Date
- 2020-02-05
- Peptides
- Envelope glycoprotein gp120: AEI
Envelope glycoprotein gp41: BFJ
VRC01 Fab Heavy Chain: CGK
VRC01 Fab Light Chain: DHL - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AE
EI
IB
BF
FJ
JC
CG
GK
KD
DH
HL
L
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-3-mer
- Ligands
- 3 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 21 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 12 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 15 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Henderson, R. et al., Disruption of the HIV-1 Envelope allosteric network blocks CD4-induced rearrangements. Nat Commun (2020)
- Release Date
- 2020-02-05
- Peptides
- Envelope glycoprotein gp120: AEI
Envelope glycoprotein gp41: BFJ
VRC01 Fab Heavy Chain: CGK
VRC01 Fab Light Chain: DHL - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AE
EI
IB
BF
FJ
JC
CG
GK
KD
DH
HL
L